Robust two-gene classifiers for cancer prediction  by Wang, Xiaosheng
Genomics 99 (2012) 90–95
Contents lists available at SciVerse ScienceDirect
Genomics
j ourna l homepage: www.e lsev ie r .com/ locate /ygenoRobust two-gene classiﬁers for cancer prediction
Xiaosheng Wang
Biometric Research Branch, National Cancer Institute, National Institutes of Health, Rockville, MD 20852, USAE-mail address: xiaosheng.wang@nih.gov.
0888-7543/$ – see front matter. Published by Elsevier I
doi:10.1016/j.ygeno.2011.11.003a b s t r a c ta r t i c l e i n f oArticle history:
Received 6 September 2011
Accepted 9 November 2011
Available online 27 November 2011
Keywords:
Cancer
Classiﬁcation
Gene expression proﬁling
Information entropy
Computational biologyTwo-gene classiﬁers have attracted a broad interest for their simplicity and practicality. Most existing two-gene
classiﬁcation algorithms were involved in exhaustive search that led to their low time-efﬁciencies. In this
study, we proposed two new two-gene classiﬁcation algorithms which used simple univariate gene selection
strategy and constructed simple classiﬁcation rules based on optimal cut-points for two genes selected. We
detected the optimal cut-point with the information entropy principle. We applied the two-gene classiﬁcation
models to eleven cancer gene expression datasets and compared their classiﬁcation performance to that of
some established two-gene classiﬁcation models like the top-scoring pairs model and the greedy pairs model,
aswell as standardmethods including Diagonal Linear Discriminant Analysis, k-Nearest Neighbor, Support Vector
Machine and Random Forest. These comparisons indicated that the performance of our two-gene classiﬁers was
comparable to or better than that of compared models.
Published by Elsevier Inc.1. Introduction
Many studies have made it a growing consensus that to deal with
high-dimensional gene expression data, simple classiﬁers often have
substantial advantages over complicated ones [1–7]. One advantage
is that simple classiﬁers often have better classiﬁcation performance
but lower computational cost than complex classiﬁers. Another ad-
vantage is that simple classiﬁers are more interpretable and applica-
ble compared to complex classiﬁers because they are often involved
in a small number of genes and simple classiﬁcation rules. As a typical
representative of simple classiﬁers, the two-gene classiﬁer has
attracted an increasing interest [8–17]. Among them, the top-
scoring pair(s) (TSP) classiﬁer classiﬁes phenotypes according to the
relative expression of a pair of genes as contributes to its two advan-
tages: ﬁrst, it avoids over-ﬁtting by eliminating speciﬁc parameter
tuning; second, it is not affected by normalization issues [8–9]. In
[17], the authors proposed gene-pair based methods to select gene
sets which well distinguished two classes. In [3], the authors screened
a small number of informative gene pairs on the basis of their
depended degrees proposed in rough sets by which the decision
rules were induced to classify phenotypes classes. These two-gene
classiﬁcation algorithms indicated that gene pairs in combination
might better discriminate different classes than individual genes
due to gene interactions.
Although class predictionmight be improved by taking advantage of
the gene-interaction information, the relevant algorithms were often
time-consuming. Moreover, these algorithms were often involved in
complex multivariate gene selection approach, which has been provennc.not to bemore effective than simple univariate gene selection approach
in most cases [7,18]. In this study, we proposed two new two-gene
classiﬁcation algorithms based on univariate gene selection strategy.
We simply selected two genes with the largest absolute t-statistic
values, and then constructed classiﬁcation rules based on their optimal
cut-points of expression levels. We detected the optimal cut-point
according to the information entropy principle [19].
We compared the performance of the two-gene classiﬁcation
models to that of the TSP [8] and the greedy pairs (GP) based classiﬁca-
tion models [17]. We also compared the performance of our classiﬁers
with the popularly-used standard models including Diagonal Linear
Discriminant Analysis (DLDA), k-Nearest Neighbor (k-NN), Support
VectorMachines (SVM) and Random Forest (RF). Thematerials studied
involved eleven publicly available gene expression datasets (http://
linus.nci.nih.gov/~brb/DataArchive_New.html) [20].
2. Methods
2.1. Construction of two-gene classiﬁers
Within each training set, we calculated the value of the t-statistic
(t-score) for each gene, and then selected the two genes with the
highest absolute values of t-score to build classiﬁcation rules. Here
we obtained the t-score based on the Welch's t-test which supposes
two groups of samples have possibly unequal variances.
We built the classiﬁcation rules based on the optimal cut-points
for the expression levels of the genes selected. We found the optimal
cut-point by using the entropy-based discretization method [19].
In [21], we have given the description of the method for detection
of the optimal cut-point. Here we simply repeated the essential
procedure.
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training sample set S as s1, s2, …, sn, based on the expression levels
of g, and then constructed the candidate cut-point set P which was
composed of the mean values of E(g, sk) and E(g, sk+1) provided
that sk and sk+1 were labeled with two different classes. Here E(g, si)
denotes the expression level of gene g in the sample si. Each element
t of P separated S into two equivalence classes S1(t, g) and S2(t, g),
where S1(t, g)={s∈S | E(g, s)≤ t} and S2(t, g)={s∈S | E(g, s)>t}. Let
C1 denote the subset of samples whose class label is c1, and C2 the sub-
set of samples whose class label is c2. Deﬁne the four sets: P11, P12, P21
and P22, where P11=S1(t, g)∩C1, P12=S1(t, g)∩C2, P21=S2(t, g)∩C1,
and P22=S2(t, g)∩C2. We calculated the class information entropy of
the partition induced by t, denoted E(g, t, S), as follows:
E g; t; Sð Þ ¼− S1j j
Sj j
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S1j j
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:
We selected the t which minimized E(g, t, S) as the optimal
cut-point T(g) for g. If the candidate cut-point set P was empty
(very rare), we took the mean expression level of g in all training
samples as the optimal cut-point.
Once we obtained the optimal cut-point T(g) for the gene g,
we built the single-gene classiﬁcation rule based on g. Let Q11(g)=
S1(T(g), g)∩C1, Q12(g)=S1(T(g), g)∩C2, Q21(g)=S2(T(g), g)∩C1, Q22
(g)=S2(T(g), g)∩C2, and C(s) denote the class label assigned to the
sample s. If |Q11(g)|+|Q22(g)|>|Q12(g)|+|Q21(g)|, the classiﬁcation
rule would be “E(g, s)≤T(g)=>C(s)=c1; E(g, s)>T(g)=>C(s)=
c2”; otherwise, the classiﬁcation rule would be “E(g, s)≤T(g)=>
C(s)=c2; E(g, s)>T(g)=>C(s)=c1”.
We have used the above classiﬁcation rule to construct single-gene
classiﬁers by which we achieved ideal classiﬁcation effect in most
cases [21]. However, the single-gene classiﬁers' performance would
degrade if one noise genewas selected. The present two-gene classiﬁers
were expected to attain more stable performance through combination
of the classiﬁcation rules induced by two genes. Here we constructed
two types of two-gene classiﬁers termed as TGC-1 and TGC-2,
respectively.
Suppose we selected another gene h with the second largest
absolute t-score, apart from the gene g which had the largest absolute
t-score. We denoted max(x, y) as the larger one between x and y. We
constructed TGC-1's classiﬁcation rule as follows: if max(|Q11(g)|+
|Q22(g)|, |Q12(g)|+ |Q21(g)|)≥max(|Q11(h)|+ |Q22(h)|, |Q12(h)|+
|Q21(h)|), then the classiﬁcation rule is the single-gene classiﬁcation
rule based on g; otherwise, the classiﬁcation rule is the single-gene
classiﬁcation rule based on h.C1 C2
Q11(g) Q12(g)S1(T(g), g)
S2(T(g), g) Q21(g) Q22(g)
Yes
max(|Q11(g)|+|Q22(g)|
max(|Q11(h)|+|Q22(h)|
Adopt the classification rule built by g
Fig. 1. Construction of TGC-1's classiﬁcation rule.TGC-1's classiﬁcation rule is built based o
classiﬁed with gene g and h.Heremax(|Q11(g)|+|Q22(g)|, |Q12(g)|+|Q21(g)|) andmax(|Q11(h)|+
|Q22(h)|, |Q12(h)|+|Q21(h)|) indicate the number of samples correctly
classiﬁed with gene g and h, respectively. Therefore, TGC-1 utilized the
classiﬁcation rule constructed merely based on one of the two selected
genes which led to the optimal classiﬁcation result (Fig. 1).
In contrast, we constructed TGC-2's classiﬁcation rule by taking
into account the classiﬁcation rules based on both genes selected
simultaneously. As for a single gene x, we will encounter two
cases: |Q11(x)|+|Q22(x)|>|Q12(x)|+|Q21(x)| and |Q11(x)|+|Q22(x)|≤
|Q12(x)|+|Q21(x)|, we will have four different combinations for
two genes. On the other hand, relative to the optimal cut-point,
the expression level of gene x in a sample s can be divided into
two cases: E(x, s)≤T(x) and E(x, s)>T(x). Thus, the expression
levels of two genes in the same sample s will have four different
possibilities. Suppose we classify s into class c1 and c2 by the clas-
siﬁcation rules based on gene x and y, respectively. If c1 is identical
to c2, we will certainly classify s into class c1 (or c2); otherwise,
we need to consider additional factors to determine the class
label of s. One signiﬁcant factor is the distance between the expression
level of one gene and its optimal cut-point. If the distance regarding
gene x is greater than that regarding gene y, we think that x has higher
weight than y in determining the class attribute of s, and therefore
adopt its classiﬁcation rule to classify s. Because different genes possibly
have very different average expression levels across samples, we nor-
malized the distance via dividing it by the average expression level of
each gene across all training samples. Fig. 2 illuminates the basic proce-
dure of TGC-2.
In detail, we constructed TGC-2's classiﬁcation rule as follows:
(1) if |Q11(g)|+|Q22(g)|>|Q12(g)|+|Q21(g)| and |Q11(h)|+|Q22(h)|>
|Q12(h)|+|Q21(h)|, then
1) E(g, s)≤T(g) and E(h, s)≤T(h)=>C(s)=c1;
2) E(g, s)>T(g) and E(h, s)>T(h)=>C(s)=c2;
3) if E(g, s)>T(g) and E(h, s)≤T(h), then
a) (E(g, s)−T(g))/|mean(g)|b(T(h)−E(h, s))/|mean(h)|=>
C(s)=c1;
b) (E(g, s)−T(g))/|mean(g)|≥ (T(h)−E(h, s))/|mean(h)|=>
C(s)=c2;
4) if E(g, s)≤T(g) and E(h, s)>T(h), then
a) (T(g)−E(g, s))/|mean(g)|≥ (E(h, s)−T(h))/|mean(h)|=>
C(s)=c1;
b) (T(g)−E(g, s))/|mean(g)|b(E(h, s)−T(h))/|mean(h)|=>
C(s)=c2;
(2) if |Q11(g)|+|Q22(g)|>|Q12(g)|+|Q21(g)| and |Q11(h)|+|Q22(h)|≤
|Q12(h)|+|Q21(h)|, then
1) E(g, s)≤T(g) and E(h, s)>T(h)=>C(s)=c1;C1 C2
Q11(h) Q12(h)S1(T(h), h)
S2(T(h), h) Q21(h) Q22(h)
No
, |Q12(g)|+|Q21(g)|)
, |Q12(h)|+|Q21(h)|) ?
Adopt the classification rule built by h
n a single gene's classiﬁcation rule by comparison of the number of samples correctly
C1                    C2 C1 C2
Q11(g) Q12(g) Q11(h) Q12(h)S1(T(g), g)
S2(T(g), g) Q21(g) Q22(g)
S1(T(h), h)
S2(T(h), h) Q21(h) Q22(h)
Classify s to c1 Classify s to c2
Yes
 No                                                                            
Yes
 No
Classify s to c1 (or c2)
Classify s to c2
Build the classification rule based on g Build the classification rule based on h
c1= c2?
|(E(g, s)-T(g))/mean(g)| 
|(E(h, s)-T(h))/mean(h)| ?
Classify s to c1
Fig.2. Construction of TGC-2's classiﬁcation rule.TGC-2's classiﬁcation rule is built by the weighted consideration of two single genes' classiﬁcation rules.
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3) if E(g, s)>T(g) and E(h, s)>T(h), then
a) (E(g, s)−T(g))/|mean(g)|b(E(h, s)−T(h) )/|mean(h)|=>C(s)=
c1;
b) (E(g, s)−T(g))/|mean(g)|≥ (E(h, s)−T(h) )/|mean(h)|=>
C(s)=c2;
4) if E(g, s)≤T(g) and E(h, s)≤T(h), then
a) (T(g)−E(g, s))/|mean(g)|≥ (T(h)−E(h, s))/|mean(h)|=>
C(s)=c1;
b) (T(g)−E(g, s))/|mean(g)|b(T(h)−E(h, s))/|mean(h)|=>
C(s)=c2;
(3) if |Q11(g)|+|Q22(g)|≤ |Q12(g)|+|Q21(g)| and |Q11(h)|+|Q22(h)|>
|Q12(h)|+|Q21(h)|, then
1) E(g, s)>T(g) and E(h, s)≤T(h)=>C(s)=c1;
2) E(g, s)≤T(g) and E(h, s)>T(h)=>C(s)=c2;
3) if E(g, s)>T(g) and E(h, s)>T(h), then
a) (E(g, s)−T(g))/|mean(g)|≥(E(h, s)−T(h))/|mean(h)|=>C(s)=
c1;
b) (E(g, s)−T(g))/|mean(g)|b(E(h, s)−T(h))/|mean(h)|=>C(s)=
c2;
4) if E(g, s)≤T(g) and E(h, s)≤T(h), then
a) (T(g)−E(g, s))/|mean(g)|b(T(h)−E(h, s))/|mean(h)|=>C(s)=
c1;
b) (T(g)−E(g, s))/|mean(g)|≥(T(h)−E(h, s))/|mean(h)|=>C(s)=
c2;
(4) if |Q11(g)|+|Q22(g)|≤ |Q12(g)|+|Q21(g)| and |Q11(h)|+|Q22(h)|≤
|Q12(h)|+|Q21(h)|, then
1) E(g, s)>T(g) and E(h, s)>T(h)=>C(s)=c1;
2) E(g, s)≤T(g) and E(h, s)≤T(h)=>C(s)=c2;
3) if E(g, s)>T(g) and E(h, s)≤T(h), then
a) (E(g, s)−T(g))/|mean(g)|≥(T(h)−E(h, s))/|mean(h)|=>C(s)=
c1;
b) (E(g, s)−T(g))/|mean(g)|b(T(h)−E(h, s))/|mean(h)|=>C(s)=
c2;
4) if E(g, s)≤T(g) and E(h, s)>T(h), then
a) (T(g)−E(g, s))/|mean(g)|b(E(h, s)−T(h))/|mean(h)|=>C(s)=
c1;
b) (T(g)−E(g, s))/|mean(g)|≥(E(h, s)−T(h))/|mean(h)|=>C(s)=
c2;Here mean(i) indicates the average expression levels of gene i
across all training samples.
2.2. Evaluation of classiﬁer performance
We evaluated classiﬁer performance by leave-one-out cross
validation (LOOCV). In each leave-one-out training set, we selected
two genes based on which the classiﬁcation rule was constructed to
classify the omitted sample. We used TGC-1 and TGC-2 to classify each
dataset, respectively, and thus we obtained two sets of classiﬁcation
accuracy results.
We compared the performance of our models to that of the gene
pairs based classiﬁcation models TSP and GP, as well as four standard
classiﬁers: DLDA, k-NN, SVM and RF. For the TSP classiﬁer, the number
of gene pairs selectedwas set as one. For the GPmodel, we ﬁrst selected
one pair of genes based on the greedy-pairs approach proposed in
[17], and then used DLDA, k-NN and SVM algorithms to perform classi-
ﬁcation with the two genes selected, respectively. For k-NN, we set the
parameter k as 3. The SVMwas based on the linear inner product kernel
function (cost=1). For RF, we set the number of trees and genes ran-
domly sampled as candidates at each split as 100 and the squared root
of the total number of genes, respectively. For the four standard classi-
ﬁers, the genes signiﬁcantly different between the classes at 0.001 sig-
niﬁcance level were used for class prediction. We carried out all the
compared classiﬁcation algorithms in BRB-ArrayTools, an integrated
package for the visualization and statistical analysis of DNA microarray
gene expression data (http://linus.nci.nih.gov/BRB-ArrayTools.html)
[22].
2.3. Materials
We selected eleven gene expression datasets to evaluate classiﬁer
performance. These datasets have different scale of sample size and
gene number. For the Melanoma, Breast Cancer 2, Gastric Tumor,
Lung Cancer 2 and Myeloma datasets, we performed pre-ﬁltering of
gene due to computational cost. Thus, the gene numbers presented
in the ﬁve datasets are post-ﬁltering gene numbers, while the gene
numbers shown in the other datasets are the original gene numbers
published (Table 1).
Table 1
Summary of the eleven gene expression datasets.
Dataset # Genes Class # Samplesa
Melanoma [23] 18256 Malignant/nonmalignant 70 (45/25)
Breast Cancer 1 [24] 7650 Relapse/no-relapse 99 (45/54)
Brain Cancer [25] 7129 Classic/desmoplastic 60 (46/14)
Breast Cancer 2 [15] 17985 Disease-free/cancer recurred 60 (32/28)
Gastric Tumor [26] 7195 Normal/tumor 132 (29/103)
Lung Cancer 1 [27] 12600 Squamous cell lung carcinoma/pulmonary carcinoid 41 (21/20)
Lung Cancer 2 [28] 6321 Mesothelioma/adenocarcinoma 181 (31/150)
Lymphoma [29] 7129 Cured/fatal 58 (32/26)
Myeloma [30] 6451 Without bone lytic lesion/with bone lytic lesion 173 (36/137)
Pancreatic Cancer [31] 22283 Normal/pancreatic ductal carcinoma 49 (25/24)
Prostate Cancer [32] 12600 Normal/tumor 102 (50/52)
a Note: The sample size of each class is given in parenthesis.
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3.1. Comparison with the TSP classiﬁer
Table 2 lists the LOOCV results for TSP, TGC-1 and TGC-2. From
Table 2, we can see that in the Melanoma, Brain Cancer, Lung Cancer
1, Lung Cancer 2 and Lymphoma datasets, the classiﬁcation accuracy
obtained by our methods matches that obtained by TSP. In the Breast
Cancer 1, Myeloma and Pancreatic Cancer datasets, TSP shows higher
accuracy than our methods, while in the Breast Cancer 2, Gastric
Tumor and Prostate Cancer datasets, our methods exhibit higher ac-
curacy than TSP. Generally speaking, for the datasets examined, our
two-gene classiﬁers show comparable performance with TSP.
3.2. Comparison with the GP model
Table 3 compares the classiﬁcation accuracy by our models to that
by DLDA, k-NN, and SVM with the GP gene selection approach. Here
we term the classiﬁcation models based on the GP gene selection
approach the GP model regardless of what classiﬁcation rule is used.
From Table 3, we can see that in theMelanoma, Brain Cancer, Breast
Cancer 2 and Gastric Tumor datasets, the classiﬁcation accuracy
obtained by our methods are higher than that obtained by GP. In Breast
Cancer 1, Lung Cancer 1, Lung Cancer 2, Pancreatic Cancer and Prostate
Cancer datasets, our methods and GP achieved close accuracy. In the
Lymphoma andMyeloma datasets, ourmethods exhibit a bit poorer ac-
curacy than GP. Overall, our two-gene classiﬁcation models surpassed
GP in prediction performance for the datasets examined.
3.3. Comparison with the standard classiﬁers
Table 4 compares the classiﬁcation accuracy between the two-gene
classiﬁers and the standard classiﬁers. From Table 4, we can see that inTable 2
Comparison of classiﬁcation accuracy (%) with the TSP classiﬁer.
Method TSP TGC-1 TGC-2
Dataset
Melanoma 99 97 96
Breast Cancer 1 75 64 64
Brain Cancer 77 77 75
Breast Cancer 2 70 82 78
Gastric Tumor 66 89 88
Lung Cancer 1 95 98 100
Lung Cancer 2 94 93 93
Lymphoma 57 59 60
Myeloma 79 68 54
Pancreatic Cancer 90 71 73
Prostate Cancer 81 89 90the Breast Cancer 1, Brain Cancer, Breast Cancer 2 and Pancreatic Cancer
datasets, our methods consistently achieved higher accuracy than all
the standard classiﬁers. In Melanoma, Gastric Tumor, Lung Cancer 1,
Lung Cancer 2, Lymphoma and Prostate Cancer datasets, our methods
show comparable performance with the standard classiﬁers. Only in
the Myeloma dataset, our methods exhibit poorer accuracy than the
standard classiﬁers. All together, these results indicate that our two-
gene classiﬁers have better performance than the standard classiﬁers
for the datasets examined, lending a support to the notion that simple
models outstrip complicated ones in molecular prediction of cancer
based on gene expression proﬁling.
Indeed, the average number of genes used for building the standard
classiﬁers ranged from tens to thousands, whereas their performance
was not superior to the two-gene classiﬁers. One sensible explanation
is that for the gene expression data involving high-dimensional attri-
butes (p) and low-dimensional instances (n), if too many attributes
are selected for construction of classiﬁers, over-ﬁtting is likely to occur.
4. Discussion and conclusions
For the p>n problem such as microarray classiﬁcation, good
performance can often be achieved with a small number of genes,
even a pair of genes. Indeed, in some cases, accurate classiﬁcation can
be achieved with one single gene [3,21]. Previously, we developed the
single-gene models which were frequently of commensurate accuracy
as more complex classiﬁers, whereas in some cases, the single-gene
models performed poorly because of the selection of noise genes [21].
The present two-gene classiﬁcation models to a large extent overcame
the unstability drawback of the single-gene models because it is highly
improbable to select two noise genes simultaneously.
We can't evaluate the complexity of a classiﬁcation model simply
based on the number of genes in the model. Complexity also depends
on gene selection criteria and classiﬁcation rules employed. Simple
models typically involve a simple feature selection scheme and simpleTable 3
Comparison of classiﬁcation accuracy (%) with the GP model.
Method TGC-1 TGC-2 GP
Dataset DLDA k-NN SVM
Melanoma 97 96 86 90 84
Breast Cancer 1 64 64 74 60 68
Brain Cancer 77 75 67 63 67
Breast Cancer 2 82 78 62 57 60
Gastric Tumor 89 88 80 77 81
Lung Cancer 1 98 100 98 95 95
Lung Cancer 2 93 93 86 89 91
Lymphoma 59 60 69 64 67
Myeloma 68 54 60 69 78
Pancreatic Cancer 71 73 78 76 73
Prostate Cancer 89 90 87 82 85
Table 5
Comparison of classiﬁcation accuracy (%) with the alternative two-gene classiﬁer.
Method TGC-Mm TGC-1 TGC-2
Dataset
Melanoma 97 97 96
Breast Cancer 1 64 64 64
Brain Cancer 75 77 75
Breast Cancer 2 78 82 78
Gastric Tumor 89 89 88
Lung Cancer 1 98 98 100
Lung Cancer 2 95 93 93
Lymphoma 52 59 60
Myeloma 47 68 54
Pancreatic Cancer 63 71 73
Prostate Cancer 88 89 90
Table 4
Comparison of classiﬁcation accuracy (%) with the standard classiﬁers.
Method TGC-1 TGC-2 DLDA k-NN SVM
Dataset
Melanoma 97 96 97 97 97
Breast Cancer 1 64 64 53 52 43
Brain Cancer 77 75 73 60 70
Breast Cancer 2 82 78 70 72 70
Gastric Tumor 89 88 96 98 92
Lung Cancer 1 98 100 98 98 98
Lung Cancer 2 93 93 99 99 99
Lymphoma 59 60 52 59 57
Myeloma 68 54 80 76 79
Pancreatic Cancer 71 73 61 65 55
Prostate Cancer 89 90 93 93 93
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cated feature selection procedures and/or complicated classiﬁcation
rules [21]. Although TSP, GP and our models were all involved in gene
pairs, TSP and GP were actually more complex than our models. The
TSP algorithm performed gene pair selection by searching for all gene
pair combinations that is computationally expensive. The GP algorithm
evaluated a subset of all gene pair combinations by ﬁrst ranking all
genes based on individual t-score, which was less computationally ex-
pensive than the TSP algorithm but more computationally expensive
than our algorithm. Indeed, neither of TSP and GP was a genuine two-
gene classiﬁcation algorithm in that they actually embraced multiple
gene pairs in construction of classiﬁcation rules.
Our algorithm selected two genes on the basis of their individual
t-score. Therefore, gene interaction information was not considered
by our strategy. In fact, the detection of interaction between genes
among thousands or tens of thousands candidates is very time-
consuming. That was why the TSP and GP algorithms had lower
time efﬁciency than our algorithm. In fact, gene interaction information
might not exert a signiﬁcant inﬂuence on classiﬁcation performance
[7,18].
The classiﬁcation accuracies obtained by TGC-1 and TGC-2were very
close to each other except for in the Myeloma dataset. Both classiﬁers
utilized the identical two genes but different classiﬁcation rules. Actual-
ly, the classiﬁcation rule used by TGC-1 was the single-gene classiﬁca-
tion rule. Its excellent performance manifested that the single-gene
classiﬁcation rule was a reasonable choice if the single gene selected
was not a noise gene. In contrast, TGC-2 indeed used the two gene se-
lected to construct the classiﬁcation rule which was more complex
than that of TGC-1. Thus, the performance of TGC-2 relied on both
genes while the performance of TGC-1 depended upon only one of
both genes. That means TGC-1 is a more robust classiﬁer than TGC-2 in
that any one noise gene in the gene pair selected will comprise the per-
formance of TGC-2 but not affect that of TGC-1 if the other gene is infor-
mative. The great gap between the classiﬁcation accuracies produced by
TGC-1 and TGC-2 in the Myeloma dataset may exemplify this point.
Here we selected two genes with the largest absolute values of
t-score. An alternative approach is to select two genes with one gene
having the largest positive value of t-score and another gene having
the smallest negative value of t-score. This approach seems to be a sen-
sible choice in that based on it, we may select one gene with much
higher expression levels in one class and another gene with much
higher expression levels in another class. In fact, many two-gene classi-
ﬁers select gene pairs based on similar criteria including the TSP classi-
ﬁer, and our method has 50% chance of meeting this selection. Table 5
compares the performance between TGC-1, TGC-2 and the two-gene
classiﬁer constructed based on the alternative gene selection approach
and the same classiﬁcation rule as that used by TGC-2 (TGC-Mm). Ap-
parently, inmost cases, the alternative two-gene classiﬁer has compara-
ble performancewith TGC-1and TGC-2, whereas in a few cases, it shows
poorer performance than TGC-1 and TGC-2 such as in the Lymphoma,Myeloma and Pancreatic Cancer datasets. One possible explanation for
the performance gap in these datasets is that there may are much
more genes having obviously higher expression levels in one class
(class 1) than in another class (class 2) in these datasets so that the se-
lection of two geneswith higher expression levels in class 1 ismore rea-
sonable than the selection of two geneswith higher expression levels in
class 1 and class 2, respectively.
In this study, we developed genuine two-gene classiﬁcation
models. Through experimental test on several gene expression data-
sets, we found that although our two-gene classiﬁcation algorithms
were simpler than existing two-gene classiﬁcation algorithms like
TSP and GP, our classiﬁers' performance was comparable to or better
than that of TSP and GP. Moreover, our classiﬁers exhibited better
performance than the standard classiﬁers DLDA, k-NN, SVM and RF,
even though they used much more genes for classiﬁcation. This
study strengthens the consensus that simple classiﬁers have essential
advantages over complicated ones, and therefore should be prefera-
ble for cancerous prediction based on gene expression proﬁling.
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